News that matters
A large study suggests that GLP-1 drugs including Ozempic and Mounjaro may slightly increase the risk of hair loss in people with type 2 diabetes. Compared with two other common classes of diabetes medications, GLP-1 users had a significantly higher rate of alopecia, though the absolute risk was still low. The hair loss was mainly non-scarring, which means it may be reversible.
Source: ScienceDaily
The U.S. National Science Foundation supports the Administration’s commitment to securing American leadership in quantum information science and technology. This executive order reflects a clear-eyed […]
When it comes to making a mess, not even the world’s crumbliest cookie would compare to a photon. Photons are fundamental particles of light. As […]
The medical device industry is undergoing a massive transformation. From AI-powered diagnostic tools to wearable health trackers and robotics, companies are innovating at lightning speed. […]